ENDOGLIN MRNA EXPRESSION IS INCREASED IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH POOR PROGNOSTIC MARKERS

被引：0
|
作者：
Vrbacky, F.
Nekvindova, J.
Vroblova, V.
Simkovic, M.
Jiruchova, Z.
Maly, J.
Smolej, L.
机构：
[1] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Univ Hosp, Hradec Kralove, Czech Republic
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1271
引用
收藏
页码：518 / 519
页数：2
相关论文
共 50 条
  • [21] Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers
    Amaya-Chanaga, Carlos I.
    Rassenti, Laura Z.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2016, 29 (01) : 79 - 89
  • [22] Cancer testicular antigens as a prognostic markers of chronic lymphocytic leukemia
    Chavez, Julio C.
    Domingo, Gelenis
    Dalia, Samir
    Dubovsky, Jason A.
    Berchmans, Emmanuel
    Powers, John Joseph
    Sweet, Kendra Lynn
    Crescentini, Robert M.
    Sotomayor, Eduardo M.
    Komrokji, Rami S.
    Pinilla-Ibarz, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Fcgammariib Expression As a Prognostic Marker in Chronic Lymphocytic Leukemia
    Bosch, Rosa
    Ferrer, Gerardo
    Vicente, Eva Puy
    Mora, Alba
    Damie, Rajendra N.
    Gorlatov, Sergey
    Rai, Kanti
    Montserrat, Emili
    Sierra, Jorge
    Chiorazzi, Nicholas
    Moreno, Carol
    BLOOD, 2015, 126 (23)
  • [24] Increased bone marrow angiogenesis is of prognostic relevance in patients with chronic lymphocytic leukemia.
    Sezer, O
    Niemöller, K
    Jakob, C
    Zavrski, I
    Heider, U
    Eucker, J
    Fietze, E
    Blau, I
    Krenn, V
    Possinger, K
    BLOOD, 2001, 98 (11) : 361A - 361A
  • [25] THE RELATIONSHIP BETWEEN CD317 EXPRESSION AND PROGNOSTIC MARKERS CD38 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Urlu, S.
    Avci, D.
    Genc, E.
    Pamukcuoglu, M.
    Ucar, M.
    Akat, G. Korkmaz
    Falay, M.
    Ceran, F.
    Dagdas, S.
    Ozet, G.
    LEUKEMIA RESEARCH, 2017, 61 : S28 - S29
  • [26] Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers
    Teodora Karan-Djurasevic
    Vuk Palibrk
    Branka Zukic
    Vesna Spasovski
    Irena Glumac
    Milica Colovic
    Natasa Colovic
    Vladimir Jurisic
    Andreas Scorilas
    Sonja Pavlovic
    Natasa Tosic
    Medical Oncology, 2013, 30
  • [27] Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers
    Karan-Djurasevic, Teodora
    Palibrk, Vuk
    Zukic, Branka
    Spasovski, Vesna
    Glumac, Irena
    Colovic, Milica
    Colovic, Natasa
    Jurisic, Vladimir
    Scorilas, Andreas
    Pavlovic, Sonja
    Tosic, Natasa
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [28] Screening for Cytotoxic Compounds in Poor-prognostic Chronic Lymphocytic Leukemia
    Norberg, Maria
    Lindhagen, Elin
    Kanduri, Meena
    Rickardson, Linda
    Sundstrom, Christer
    Stamatopoulos, Kostas
    Rosenquist, Richard
    Aleskog, Anna
    ANTICANCER RESEARCH, 2012, 32 (08) : 3125 - 3136
  • [29] The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Soma, LA
    Craig, FE
    Swerdlow, SH
    HUMAN PATHOLOGY, 2006, 37 (02) : 152 - 159
  • [30] Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia
    Karabon, Lidia
    Partyka, Anna
    Jasek, Monika
    Lech-Maranda, Ewa
    Grzybowska-Izydorczyk, Olga
    Bojarska-Junak, Agnieszka
    Pawlak-Adamska, Edyta
    Tomkiewicz, Anna
    Robak, Tadeusz
    Rolinski, Jacek
    Frydecka, Irena
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 : S137 - S145
12345